Study to Assess Satisfaction in Patients Treated With Copaxone®

- Multiple Sclerosis
- Completed

Study Title: Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxoneֲ®

Teva Identifier: TV44400-CNS-40083 | 2015-000922-12

ClinicalTrials.gov Identifier: NCT02499900

Study Status: Completed

Trial Condition(s): Multiple Sclerosis

Interventions: Drug: Copaxoneֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: August 10, 2015 - June 2, 2017

Phase: Phase 4

Study Type

Interventional